Selected Balance Sheet Information

9 Months Ended

Sep. 30, 2023

Selected Balance Sheet Information

Selected Balance Sheet Information

7. Selected Balance Sheet Information

Prepaid expenses and other current assets (in thousands)

	September 30,		December 31,
	2023		2022
Prepaid clinical research organizations	$	1,190	$	2,293
Prepaid manufacturing expenses		501		418
Prepaid consulting, subscriptions and other expenses		227		155
Prepaid insurance		114		637
VAT receivable		176		87
Receivable from Grifols		—		144
Total	$	2,208	$	3,734

Prepaid clinical research organizations (CROs) expense is classified as a current asset. The Company makes payments to the CROs based on agreed upon terms that include payments in advance of study services. Receivable from Grifols includes amounts due related to research and development tax rebates, VAT and corporate taxes.

7. Selected Balance Sheet Information – (continued)

Property and equipment, net (in thousands)

	September 30,		December 31,
	2023		2022
Computers and office equipment	$	901	$	897
Other property, plant and equipment		342		208
Leasehold improvements		94		94
Software		11		11
		1,348		1,210
Less: accumulated depreciation and amortization		(959)		(865)
Total	$	389	$	345

Accrued expenses (in thousands)

	September 30,		December 31,
	2023		2022
Milestone due to Grifols	$	3,250	$	—
Accrued clinical consulting services		1,353		807
Accrued manufacturing costs		640		197
Accrued vendor payments		347		492
Total	$	5,590	$	1,496

Accrued employee benefits (in thousands)

	September 30,		December 31,
	2023		2022
Accrued bonus expense	$	933	$	1,216
Accrued compensation expense		206		87
Accrued vacation expense		130		100
Total	$	1,269	$	1,403